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TO investigate effect of MMLA, an inhibitor of nitric
oxide (NO) production, on regulation of inflamma-
tory responses to Bordetella pertussis infection, mice
were infected intranasally, and treated with various
concentrations  of  MMLA.  Ten  days  after  infection,
mice treated with MMLA at dosage of 100mg/kg, given
intraperitoneally in a single dose or for 5 consecutive
days, showed at histopathologic examination, a sig-
nificant  decrease  of  intensity  of  inflammation
(scores,  0.6  ±  0.2  and  0.9  ±  0.5  respectively).  A
decrease of cellular accumulation of neutrophils and
lymphocytes  in  the  bronchoalveolar  lavage  (BAL)
fluid  was  observed  in  infected  mice  treated  with
MMLA, especially  at  dosage of 10 mg/kg, given in a
single dose intraperitoneally. In addition, BP-infected
mice  treated  with  MMLA  (100mg/kg,  intraperito-
neally) for 5 consecutive days showed higher mortal-
ity rate than untreated mice infected with B. pertus-
sis, and the number of B. pertussis in lungs of mice
treated with MMLA was significantly increased. How-
ever,  MMLA  treatment  of  infected  mice  had  some
effect on levels of IFN-g and nitrite/nitrate (end-stable
products of NO) in the BAL fluid. This study indicates
that NO may play a role either as microbiocidal agent
or as a modulator of immune regulation, inasmuch as
it may upregulate tissue inflammatory response to B.
pertussis.
Introduction
In  recent  years,  it has  became apparent that nitric
oxide (NO) and reactive nitrogen intermediates are
effector molecules responsible for the antimicrobial
functions  of  macrophages.1 The  release of NO  and
reactive nitrogen intermediates is an important part of
macrophage  effector  function  directed  against  a
variety  of  intracellular  pathogenic  microorganisms,
including fungi, bacteria and parasites.2–6 Bordetella
pertussis is  considered  a  facultative  intracellular
pathogen, which invades and survives within macro-
phages.7 The  mechanisms  by  which  macrophage-
derived NO kills a microbial target have not been fully
clarified, but are believed to involve toxic byproducts
of reactions with oxygen, superoxide and transition
metals. Although the role of macrophage activation in
the  killing  of  facultative  intracellular  pathogens,
including  B.  pertussis,  is  still  debated,  we  have
previously  shown  that  in  vitro murine  peritoneal
macrophages induce NO production in response to B.
pertussis and  pertussis  toxin.8 In  addition,  NO
production  was  also  observed  in  alveolar  macro-
phages from mice infected intranasally with B. pertus-
sis.8 The capacity to release NO is not a constitutive
trait  of  macrophages,  but  is  dependent  on  the
induction of a specific  cytosolic enzyme,  inducible
NO synthase.9 Regarding the pulmonary pathogen B.
pertussis, the role of NO and macrophage inducible
NO  synthase  in  host  responses  to  infection  are
unknown.
Ding et al.1 have shown that murine macrophages,
when  stimulated  with  gamma  interferon  (IFN-g )
catabolize  L-arginine  to  produce  NO,  by  releasing
reactive nitrogen intermediates. Thus, activated mac-
rophages stimulated with IFN-g seem to exert some
antimicrobial activities via induction of NO or other
reactive  nitrogen  oxides.10,11 We  have  previously
demonstrated that mice infected intranasally with B.
pertussis show  an  early  production  of  endogenous
IFN-g in the bronchoalveolar lavage (BAL) fluid.12
This study evaluates the effect of NG-monomethyl-
L-arginine (MMLA), an inhibitor of  NO synthase, in
mice infected intranasally with B. pertussis.
Materials and methods
Experimental animals and reagents
Eight-to-10 week old female NMRI mice (Morini, San
Polo d’Enza,  Italy),  weighing  15–18g  were  housed
throughout the experiments. The mice were caged in
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libitum.
B. pertussis 18323 (ATCC 9797) was grown at 35°C
on Bordet-Gengou agar containing 20% defibrinated
horse blood. The cells from freeze-dried cultures were
transferred  on  Bordet-Gengou  agar  no  more  than
twice  before  use.  On  the  final  passage,  cells  were
allowed  to  grow  20h,  and  then  suspended in  PBS
containing  1%  casamino  acids  (Difco  Laboratories,
Detroit,  MI).  Viable  counts  of  B.  pertussis were
determined by diluting samples in sterile PBS, spread-
ing 0.1ml of appropriate dilutions on Bordet-Gengou
plates, and incubating at 35°C for 3–4 days.
MMLA  was  purchased  from  Alexis  Corp.  (San
Diego, CA, USA),  nitrate reductase from Aspergillus
sp.  was  purchased  from  Boehringer  Biochemica
Mannheim (Milan, Italy), and FAD and NADPH from
Sigma Chemicals (St Louis, MO, USA).
Respiratory tract infection
An intranasal mouse model was used, as previously
described.12 Briefly, bacterial strains were dispensed
in 1% casamino acids, and adjusted to concentration
of 1 3 106 organisms/ml. Mice were lightly anaesthe-
sized with diethyl ether. A 50-m l bacterial suspension
was placed in the tips of their noses for inhalation.
Control mice were treated with saline solution. Lungs
were prepared for quantitative bacteriologic examina-
tion by removal of the heart and lungs en bloc. Lungs
and heart were then separated and placed in 10ml of
1% casamino acids. Viable counts were made after the
organs were homogenized for 10s in a homogenizer
and appropriately detected. At least five mice were
used for each experimental group.  Bronchoalveolar
lavage (BAL) fluid was recovered from the lungs by
lavage with three 1-ml aliquots of sterile saline via a
polyethylene tubing attached to a syringe. All lavages
yielded equivalent amounts, 90% of the volume of the
BAL returned. Lavage fluids from each animals were
pooled in sterile tubes and centrifuged at 400 3 g for
10min. Total  cells  were  counted  with  a  haemacyt-
ometer.  Differential  counts  were  done  on  prepara-
tions stained with Giemsa stain.
Histopathology
After lavage, the lungs  were immersed in formalin.
Parasaggital sections of fixed lung tissue were embed-
ded in paraffin, and processed for histologic examina-
tion, using haematoxylin-eosin stain. The intensity of
inflammation  caused  by  B.  pertussis infection  was
graded blindly  and validated by  three investigators,
using  a  semiquantitative  scale  ranging  from  0  (no
inflammatory  cells  in  alveolar/interstitial  spaces;
absence  of  oedema;  haemorrhage  with  <  5  ery-
throcytes in alveolar/interstitial spaces) to three (large
numbers  of  inflammatory  cells,  neutrophils  and
lymphocytes, in a generalized distribution; increased
swelling of alveolar walls and fibrinous exudate; > 15
erythrocytes  in  alveolar/interstitial  spaces).  Our
observations showed a close correlation between the
infection  and  inflammation  scores obtained by  the
three investigators.
Nitric oxide assay
NO  was  measured  through  the  spectophotometric
determination of nitrate/nitrate. To reduce nitrate to
nitrite, samples were incubated in  the presence of
40mU  of nitrate reductase, 5mM FAD, and 0.6mM
NaDPH. Nitrite was measured by a procedure based
on the Griess reaction. Samples were incubated with
the Griess reagent (1% sulphanilamide in 1N HCl and
0.15%  N-naphthylethylendiamine  dihydrochloride)
for  30min  in  the  dark  at  room  temperature  in  96
microtitre  plates.  The  absorbance  at  550nm  was
determined in an automatic reader.
IFN assay
IFN  was  assayed  as  previously  reported.12 Briefly,
L-929 cells were suspended and cultured on micro-
culture plates. Plates were incubated in the presence
of serial twofold dilution of samples (1:2 to 1:256).
Cells were then challenged with vesicular stomatitis
virus  (Istituto  Zooprofilattico, Turin,  Italy)  at  a  1:1
MOI. When cytopathic effect reached 100% in con-
trols, the plates were stained with crystal violet. The
number of units of IFN per millilitre for each sample
was estimated by comparing sample titres with the
known  number  of  units  of  IFN  activity  of  the
reference standard of IFN at a 50% end point.
Statistics
Data are expressed as mean and standard deviation
values,  and  the  results  from  various  set  of  experi-
ments were compared by the non-parametric Mann-
Whitney U-test, Welch’s t-test and Fischer’s exact test
when appropriate.
Results
Table 1 shows cellular accumulation in the BAL fluid
of mice infected with B. pertussis, and treated with
various  concentrations of  MMLA,  given  in  a  single
dose intraperitoneally. As shown, decrease of cellular
accumulation  in  the  BAL  fluid,  particularly  of  neu-
trophils,  was  noted in  mice  treated with  MMLA at
various  concentrations,  and  in  particular  in  those
treated at the dosage of 100mg/kg (13.6 ± 20.9 3 105
cells/ml vs. control treated mice: 30.8 ± 23.0 3 105
cells/ml).
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infection was evaluated in lung tissue of mice treated
with MMLA. As can be seen in Fig. 1, mice sacrified 10
days after infection with B. pertussis, showed severe
inflammation in lung tissue, with a mean inflamma-
tory score of 2.5  ± 0.3  (n =  6). At  the same time
interval  after  infection,  infected  mice  treated  with
MMLA at the dosage of 100mg/kg in  a single dose
showed an uniform decrease of inflammation (inflam-
matory  score,  0.6  ±  0.2,  n =  4;  P =  0.0286).  In
addition, mice treated with MMLA at the dosage of
100mg/kg for 5 consecutive days after infection also
showed a significant decrease of inflammatory score
(0.9 ± 0.5, n = 4; P = 0.0286) (Fig. 2). The groups of
mice treated with MMLA in a single dose, and for 5
consecutive days had a 10% and 20% mortality rate (P
= 0.0367) at day 10 post-infection respectively, with
respect to the control group (mice only treated with
B. pertussis), which had a 10% mortality rate (Table
2). In addition, there was a marked and significant
increase in  the number  of  bacteria in  the  lungs  of
mice treated with MMLA for 5 consecutive days (P =
0.0296).
Furthermore, we evaluated levels of nitrite/nitrate
in the BAL fluid of infected mice treated with various
concentrations  of  MMLA,  given  in  a  single  dose
intraperitoneally. As shown in Fig. 3, treatment with
MMLA  did  not  significantly  increase  BAL  levels  of
nitrite/nitrate,  although  a  moderate  increase  of
nitrite/nitrate  was  noted  at  a  concentration  of
100mg/kg.
Finally, levels of IFN-g were determined in the BAL
fluid of infected mice treated with MMLA. As shown
in Fig. 4, IFN-g levels were not significantly decreased
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Table  1.  Effect  of  MMLA,  given  at  various  concentrations  intraperitoneally  in  a  single  dose,  on  cells  recovered  from
bronchoalveolar lavage fluid of mice intranasally infected with B. pertussis (six mice for each experimental group). Mice were
sacrified 10 days after infection.
Treatment Total cell count
(3 10
5 cells/ml)
Differential cell count (3 10
5 cells/ml)
Neutrophils Lymphocytes Macrophages
BP 30.8 ± 23.0 24.6 ± 20.1 5.0 ± 4.8 1.2 ± 1.1
BP + MMLA 50mg/kg 15.7 ± 18.2 14.2 ± 15.8 1.0 ± 1.8 0.5 ± 0.7
BP ± MMLA 100mg/kg 13.6 ± 20.9* 11.2 ± 13.3 1.9 ± 2.0 0.5 ± 1.0
P = not significant.
FIG.  1.  Mean  inflammatory  score  of  mice  infected  intra-
nasally with B. pertussis, and treated with MMLA (100mg/kg
i.p.  in  a  single  dose).  Mice  were  sacrificed  10  days  after
infection.
FIG.  2.  Mean  inflammatory  score  of  mice  infected  intra-
nasally with B. pertussis, and treated with MMLA (100mg/kg
i.p. for  5 consecutive  days). Mice  were sacrificed  10 days
after infection.
Table 2. Number of colony-forming units of B. pertussis in lungs of mice treated or not with MMLA, and mortality rate 10 days
after they were infected intranasally with B. pertussis (10
5 cfu)
Treatment group B. pertussis (cfu 3 10
4) Mortality rate (%)
BP 105.3 ± 45.8 10
BP + MMLA (100mg/kg in a single dose) 145.5 ± 99.8 10
BP + MMLA (100mg/kg for 5 days) 190.7 ± 74.6* 20**
*P = 0.0296 respect to BP-infected mice group (Welch’s t-test);
**P = 0.0367 respect to BP-infected mice group (Fischer’s exact test).in mice treated with various concentrations of MMLA,
though a diminution of IFN-g levels in the BAL fluid
was noted in mice treated with MMLA at dosage of
50mg/kg.
Discussion
The  results  of  this  study  indicate  that  MMLA,  as
inhibitor of NO synthase, may play a role in reducing
inflammatory  response  in  mice  infected  with  B.
pertussis,  even  though  infected  mice  treated  with
MMLA for 5 consecutive days showed higher mortal-
ity rate with a concomitant increase of the number of
B. pertussis in lungs of the infected mice. Our data are
somewhat surprising, because release of NO has been
proposed as a major cellular clearance pathway for
intracellular pathogens.13 However, the in vivo role
of  macrophage  killing  of  B.  pertussis through  NO
remains unknown. Our study indicates that NO might
amplify  tissue  inflammation  through  its  effects  on
leukocyte  adhesion to  endothelium.  Kubes  et  al.14
showed  that  endothelium-derived  NO  may  be  an
important endogenous modulator of leukocyte adher-
ence, inasmuch as inhibition of NO production causes
vasoconstriction and a reduction in the shear forces
that tend to push neutrophils along venular endothe-
lium.  In  addition,  the  simultaneous  generation  of
superoxide  and  NO  by  macrophages  and  activated
neutrophils  may  cause  a  direct  lung  injury  via
peroxynitrite formation.15 Kuo et al.16 have shown
that endogenous NO may contribute to neurogenic
inflammation  in  the airways  of  guinea-pig,  through
effects on vascular smooth muscle and tissue oedema,
inasmuch as an inhibitor of NO, NG-nitro-L-arginine
methyl ester, may inhibit neurogenic plasma exuda-
tion in the guinea-pig  airways. However, the reduc-
tion of the inflammatory score in MMLA treated mice
found  in  our  study  may  be  due  to  the  severe
vasoconstriction caused by the high doses of MMLA.
Shellito  et  al.17 have  shown  that  inducible  NO
synthase does not upregulate in murine lung macro-
phages as part of the normal host response to clear
infectious challange with Pneumocystis carinii.
We  have  previously  demonstrated  that  alveolar
macrophages from mice intranasally infected with B.
pertussis show  a  significant  production  of  NO  in
vitro.8 Thus, we suggest that macrophage release of
NO  in  murine  infection  with  B.  pertussis may  be
important  in  amplifying  the  tissue  inflammatory
response to the pathogen, although we did not find a
correlation between MMLA treatment and BAL nitrite/
nitrate levels. However, endothelial cells and activated
neutrophils are mainly responsible for NO production
in the lungs after inflammatory or infectious stimuli,
as shown by increased expression of NO synthase by
these cells.14 Furthermore, NO production by alveo-
lar  macrophages,  detected  in  the  BAL  as  nitrite/
nitrate, is not increased during lung inflammation, as
these  cells  are  not  probably  involved  respect  to
parenchymal  cells,  including  endothelial  cells  and
activated neutrophils.  It  is  interesting  to  note  that
release  of  NO  by  alveolar  macrophages  can  be
blocked by glucocorticoids in vitro.18 In a histopatho-
logic study, we evaluated effects of betamethasone in
mice treated with  pertussis toxin, a major protein-
toxin of B. pertussis responsible for establishing and
maintaining the respiratory tract infection.19 In this
study, we have demonstrated that mice treated with
pertussis  toxin  and  betamethasone  showed  a
decreased congestion and oedema of the lung,  and
reduction  of  cellular  accumulation  in  parenchyma.
Inhibition of  NO release by  lung  macrophages and
consequent suppression of tissue inflammation may
be one mechanism by which glucocorticoids improve
outcome in human pertussis.20 Finally, the increased
mortality  rate  of  infected mice  treated with MMLA
together with elevation of the number of B. pertussis
in lungs of the infected mice support the role of NO
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FIG. 3. Levels of NO2/NO3 in the BAL fluid of mice infected
with  B.  pertussis,  and  treated  with  MMLA,  at  various
concentrations in a single dose intraperitoneally. Mice were
sacrificed 10 days after infection.
FIG. 4. Levels of IFN-g in the BAL fluid of mice infected with
B. pertussis, and treated with MMLA, at various concentra-
tions in a single dose intraperitoneally. Mice were sacrificed
10 days after infection.as a major clearance pathway for intracellular facul-
tative pathogens.
IFN-g is an important cytokine that modulates NO
activity  against  intracellular  infection.21,22 We  have
previously demonstrated, in vitro, that IFN-g partially
increased intracellular killing of human monocytes in
response to B. pertussis.23 In addition, no significant
increase  of  superoxide  production  was  noted  in
human monocytes in response to B. pertussis, when
stimulated with IFN-g .23 In our study, levels of IFN-g
in the BAL fluid did not significantly change in mice
treated with MMLA. In fact, NO levels in the BAL fluid
were not significantly decreased in mice treated with
various concentrations of MMLA.
In conclusion, we may suggest that NO may have a
dual function  both as microbiocidal agent and as a
modulator  of  immune  regulation,  in  particular  NO
may  upregulate  tissue inflammatory  response to  B.
pertussis.
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